CAS 113502-55-9

Ketorolac Related Compound D (5-benzoyl-2,3-dihydro-1H-pyrrolizine)

CAS : 113502-55-9

Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoi

Formule : C₁₄H₁₃NO

Couleur et forme : White Light Brown Powder

Masse moléculaire : 211.09971

Ref: 45-1356348

1-Descarboxy Ketorolac

CAS : 113502-55-9

Formule : C₁₄H₁₃NO

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 211.2591

Ref: IN-DA0008SV

Ketorolac EP Impurity I (Ketorolac USP Related Compound D)

CAS : 113502-55-9

Formule : C₁₄H₁₃NO

Couleur et forme : White To Off White Solid

Masse moléculaire : 211.26

Ref: 4Z-K-0311

Phenyl(2,3-dihydro-1H-pyrrolizin-5-yl)methanone

CAS : 113502-55-9

Couleur et forme : Neat

Ref: 86-MM0851.03

Ketorolac EP Impurity I

CAS : 113502-55-9

Formule : C₁₄H₁₃NO

Masse moléculaire : 211.26

Ref: ST-EA-CP-K4009

1-Descarboxy Ketorolac

Produit contrôlé

CAS : 113502-55-9

Applications 1-Descarboxy Ketodolac is an impurity in the synthesis of (R)-Ketorolac (K235600). The (S)-enantiomer is about 60 times more potent than (R)-enantiomer. Prostaglandin biosynthesis inhibitor. Analgesic; anti-inflammatory.
References Rooks, W.H., et al.: Agents Actions, 12, 684 (1982), Guzman, A., et al.: J. Med. Chem., 29, 589 (1986), McQuary, H.J., et al.: Clin. Pharmacol. Ther., 39, 89 (1986),

Formule : C₁₄H₁₃NO

Couleur et forme : Yellow To Dark Grey

Masse moléculaire : 211.26

Ref: TR-D289435

1-Descarboxy Ketorolac-d4

Produit contrôlé

CAS : 113502-55-9

Formule : C₁₄D₄H₉NO

Couleur et forme : Neat

Masse moléculaire : 215.284

Ref: TR-D289437

Ketorolac Related Compound D

CAS : 113502-55-9

Ketorolac Related Compound D is a racemic mixture of the optical isomers of ketorolac, which are 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid. Ketorolac Related Compound D is used as a pharmaceutical dosage form in intranasal and intranasal formulations. It has been shown to be an effective analgesic for pain relief, with the advantage of having a quick onset and short duration of action. This drug is not active when taken orally because it is not absorbed from the gastrointestinal tract. Excipients such as lactose monohydrate, magnesium stearate and talc are added to the formulation to facilitate processing and to maintain stability.

Formule : C₁₄H₁₃NO

Degré de pureté : Min. 95%

Masse moléculaire : 211.26 g/mol

Ref: 3D-NEA50255